Regulation And Legal
Lupin Receives US FDA Approval for Ranluspec
Lupin received U.S. FDA approval for RanluspecTM, an interchangeable biosimilar to Lucentis® for treating various eye diseases.
Ranluspec is the only interchangeable ranibizumab biosimilar approved in
